MedicalResearch.com Interview with:
[caption id="attachment_39585" align="alignleft" width="135"]

Dr. Efstathiou[/caption]
Jason Alexander Efstathiou,
D.,
PH.
D
Director, Genitourinary Division
Department of Radiation Oncology
Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Multidisciplinary Clinic
Massachusetts General Hospital
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: When surgery has probably failed to cure a patient, the best prospective data supports the use of postoperative radiation therapy.
The debate now centers on the optimal timing of such post-prostatectomy radiation therapy; is it adjuvant (ART) for all (with adverse pathologic features) or early salvage (ESRT) for some (who experience biochemical failure)?